Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
New York-based specialty pharmacy allegedly altered documentation, including lab test results, to obtain insurance coverage of expensive drug.
Here are some steps labs may want to take in the wake of the 2022 National Health Care Fraud Enforcement Action.
European Commission accuses sequencing giant of “jumping the gun” on Grail acquisition.
The market is expected to grow at a CAGR of 3.21 percent from 2021 to 2028 and reach $17.432 billion by 2028, according to a recent report.
Danielle H. Tangorre discusses key takeaways for labs from the DOJ’s recent nationwide takedown of $1.2 billion in alleged schemes.
Last week saw a takedown of $1.2B worth of alleged fraud schemes involving labs, genetic testing, and telemedicine.
A recent study shows that the disease was detected sooner in high-risk individuals who underwent screening than those who did not.
Centers for Disease Control and Prevention spearheads US effort to quickly increase lab testing capacity and access.
In this Q&A, Tyler Wince of Myndshft discusses the key issues labs face when it comes to benefits and prior authorization, and how technology can help.
First Special Fraud Alert in nearly two years cites six red flags of suspect arrangements with telehealth companies.